| scholarly article | Q13442814 |
| P50 | author | Lorraine Dean | Q58103923 |
| P2093 | author name string | Raheem J Paxton | |
| Jill T Owczarzak | |||
| Shadiya L Moss | |||
| Livia Frasso Jaramillo | |||
| Sarah I Rollinson | |||
| P2860 | cites work | Psychosocial impact of lymphedema: a systematic review of literature from 2004 to 2011 | Q26829705 |
| Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States. | Q27300398 | ||
| Physical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivors | Q30489696 | ||
| Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States | Q33435672 | ||
| Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens | Q33718051 | ||
| Financial cost of lymphedema borne by women with breast cancer | Q33834070 | ||
| Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world setting | Q34127931 | ||
| Dealing with the financial burden of cancer: perspectives of older breast cancer survivors | Q34287682 | ||
| National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008 | Q35114551 | ||
| The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) initiative: rationale and design | Q36698529 | ||
| The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience | Q36804490 | ||
| Financial Hardship Associated With Cancer in the United States: Findings From a Population-Based Sample of Adult Cancer Survivors | Q36914430 | ||
| Financial Insolvency as a Risk Factor for Early Mortality Among Patients With Cancer | Q37065603 | ||
| Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms | Q37104754 | ||
| Cost of a lymphedema treatment mandate-10 years of experience in the Commonwealth of Virginia | Q37230470 | ||
| "It's at a time in your life when you are most vulnerable": a qualitative exploration of the financial impact of a cancer diagnosis and implications for financial protection in health | Q37297519 | ||
| Economic burden related to chemotherapy-related adverse events in patients with metastatic breast cancer in an integrated health care system | Q37338289 | ||
| Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. | Q37415868 | ||
| Living with breast cancer-related lymphedema: a synthesis of qualitative research | Q38223548 | ||
| Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. | Q38496930 | ||
| Symptoms: Lymphedema | Q38522979 | ||
| Adverse event-related costs for systemic metastatic breast cancer treatment among female Medicaid beneficiaries | Q38840175 | ||
| For Working-Age Cancer Survivors, Medical Debt And Bankruptcy Create Financial Hardships | Q38924370 | ||
| Financial Hardships Experienced by Cancer Survivors: A Systematic Review. | Q38984073 | ||
| Return to work among breast cancer survivors: A literature review. | Q39016218 | ||
| Out-of-Pocket Spending and Financial Burden Among Medicare Beneficiaries With Cancer | Q39149082 | ||
| The impact of health insurance on cancer care in disadvantaged communities | Q39177934 | ||
| Future of cancer incidence in the United States: burdens upon an aging, changing nation | Q39983611 | ||
| Healthcare Expenditure Burden Among Non-elderly Cancer Survivors, 2008-2012. | Q40293660 | ||
| Pre-diagnosis employment status and financial circumstances predict cancer-related financial stress and strain among breast and prostate cancer survivors | Q40768565 | ||
| Financial Toxicity of Cancer Care: It's Time to Intervene | Q41058870 | ||
| Adverse breast cancer treatment effects: the economic case for making rehabilitative programs standard of care. | Q41731297 | ||
| Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer | Q42680242 | ||
| The multidimensional nature of the financial and economic burden of a cancer diagnosis on patients and their families: qualitative findings from a country with a mixed public-private healthcare system | Q45838756 | ||
| Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws | Q47221850 | ||
| Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA. | Q47551703 | ||
| Setting the stage for universal financial distress screening in routine cancer care | Q47553639 | ||
| Oncology navigators' perceptions of cancer-related financial burden and financial assistance resources | Q47619243 | ||
| As if the disease was not enough: coping with the financial consequences of cancer | Q47659080 | ||
| Complementary and Alternative Medicine and Breast Cancer | Q47667010 | ||
| Pilot Feasibility Study of an Oncology Financial Navigation Program | Q47767003 | ||
| The financial burden and distress of patients with cancer: Understanding and stepping-up action on the financial toxicity of cancer treatment. | Q48234920 | ||
| The financial burden of cancer: estimates from a study of insured women with breast cancer. | Q50747997 | ||
| Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. | Q51754850 | ||
| How Should We Intervene on the Financial Toxicity of Cancer Care? One Shot, Four Perspectives. | Q53256204 | ||
| "It still affects our economic situation": long-term economic burden of breast cancer and lymphedema | Q57168648 | ||
| Exploring the economic impact of breast cancers during the 18 months following diagnosis | Q57574376 | ||
| Communicating the Financial Burden of Treatment With Patients | Q64136329 | ||
| Family and out-of-pocket costs for women with breast cancer | Q72117017 | ||
| American Society of Clinical Oncology policy statement: opportunities in the patient protection and affordable care act to reduce cancer care disparities | Q84654502 | ||
| Chemotherapy parity laws: a remedy for high drug costs? | Q85354595 | ||
| Healthcare System Distrust, Physician Trust, and Patient Discordance with Adjuvant Breast Cancer Treatment Recommendations | Q89130234 | ||
| P433 | issue | 11 | |
| P304 | page(s) | 1929-1940 | |
| P577 | publication date | 2019-03-06 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Patient recommendations for reducing long-lasting economic burden after breast cancer | |
| P478 | volume | 125 |
| Q92850546 | Drivers of cost differences between US breast cancer survivors with or without lymphedema |
| Q89934602 | Improving Cancer Patients' Insurance Choices (I Can PIC): A Randomized Trial of a Personalized Health Insurance Decision Aid |
| Q90051057 | Insurance Coverage, Employment Status, and Financial Well-Being of Young Women Diagnosed with Breast Cancer |
Search more.